Intravascular laser blood irradiation was performed for the first time about 25 years ago in the former Soviet Union. Laser light was introduced directly into the flowing blood. Previously, in-vitro studies have shown that biological Soft laser irradiation of white blood cells trigger a variety of positive effects, in particular expression of immunoglobulins, interferons and interleukins, which are of particular importance. After introduction of the process, numerous studies were published that showed additional effects on various metabolic processes.
Weber Medical achieved approval for its intravascular laser blood irradiation apparatus in 2005 this was in part funded by a program titled Biophotonics II of the state government of Lower Saxony. Following this, Weber Medical treatment was used in Germany for the first time on patients in clinical trials. In our own studies, the results from the predominantly Russian literature are largely confirmed. We found in almost all patients a general stabilizing and energizing as well as many other positive effects in conditions like chronic liver diseases, diabetes mellitus, lipid disorders, and various other diseases. This opens new therapy options in the treatment of systemic disorders of the metabolism and immune system.